On January 27, NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)’s said that company with the FDA approving Natpara as an adjunct to calcium and vitamin D to control hypocalcemia in patients suffering from hypoparathyroidism (caused by the deficiency of parathyroid hormone/PTH). This makes Natpara the first and only bioengineered replica of human PTH to be approved by the FDA for this indication. On Monday shares of NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) closed at $45.85. Company’s sales growth for last 5 years was 8.70%.
Citigroup Inc. (NYSE:C) announced the commencement of offers to purchase for cash certain of its notes of the series set forth in the table below up to an aggregate principal amount with respect to each series of notes ()Maximum Series Tender Cap”). Citigroup Inc. (NYSE:C) in last trading activity moved up 0.14% to close at $49.21. Company weekly performance is 3.12% while its quarterly performance stands at -8.84%. Citigroup Inc. (NYSE:C) is -13.58% away from its 52 week high.
On February 2, Quanex Building Products Corporation (NYSE:NX) said that it appointed Tony Thiret to territory sales manager in the Southwest region in addition to his role as commercial sales specialist in the West. On last trading day Quanex Building Products Corporation (NYSE:NX) moved up 0.31% to close at $19.29. Its volatility for the week is 2.43% while volatility for the month is 2.72%. NX’s sales growth for past 5 years was 0.40% and its EPS growth for past 5 years was 15.60%. Quanex Building Products Corporation (NYSE:NX) monthly performance is 2.50%.
JinkoSolar Holding Co., Ltd. (NYSE:JKS) on February 5th, 2015 announced that it will provide 2 MW of smart solar photovoltaic (PV) modules to IDEC Corporation (IDEC), a Tokyo Stock Exchange listed Japanese designer and manufacturer of control automation products, for a ground mounted solar PV project in Nishinomiya, Hyogo Prefecture, Japan. On Monday shares of JinkoSolar Holding Co., Ltd. (NYSE:JKS) closed at $21.13. Company’s sales growth for last 5 years was 26.50%.
The Dow Chemical Company (NYSE:DOW) settled lawsuits by a former company fraud investigator who claimed she was wrongfully fired for uncovering improper spending by CEO Andrew Liveris and others. The Dow Chemical Company (NYSE:DOW) in last trading activity fell -0.29% to close at $48.26. Company weekly performance is 6.72% while its quarterly performance stands at -2.23%. The Dow Chemical Company (NYSE:DOW) is -10.78% away from its 52 week high.